欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/V/0124/001
药品名称AURIZON
活性成分
    • CLOTRIMAZOLE 10.0 mg/ml
    • DEXAMETHASONE acetate 1.0 mg/ml
    • MARBOFLOXACIN 3.0 mg/ml
剂型Ear drops, suspension
上市许可持有人VETOQUINOL Magny-Vernois BP189 70204 LURE - FRANCE
参考成员国 - 产品名称France (FR)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Finland (FI)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Cyprus (CY)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
许可日期2001/07/19
最近更新日期2025/06/11
药物ATC编码
    • QS02CA06 dexamethasone and antiinfectives
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full Dossier (art.5)
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase